The DOI matches its Crossref record; 332 of the 332 references it cites were found in a registry or an index.
Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use
Open accessAbstract
This paper on the fluoroquinolone resistance epidemiology stratifies the data according to the different prescription patterns by either primary or tertiary caregivers and by indication. Global surveillance studies demonstrate that fluoroquinolone resistance rates increased in the past years in almost all bacterial species except S. pneumoniae and H. influenzae, causing community-acquired respiratory tract infections. However, 10 to 30% of these isolates harbored first-step mutations conferring low level fluoroquinolone resistance. Fluoroquinolone resistance increased in Enterobacteriaceae causing community acquired or healthcare associated urinary tract infections and intraabdominal infections, exceeding 50% in some parts of the world, particularly in Asia. One to two-thirds of Enterobacteriaceae producing extended spectrum -lactamases were fluoroquinolone resistant too. Furthermore, fluoroquinolones select for methicillin resistance in Staphylococci.Neisseria gonorrhoeae acquired fluoroquinolone resistance rapidly; actual resistance rates are highly variable and can be as high as almost 100%, particularly in Asia, whereas resistance rates in Europe and North America range from <10% in rural areas to >30% in established sexual networks. In general, the continued increase in fluoroquinolone resistance affects patient management and necessitates changes in some guidelines, for example, treatment of urinary tract, intra-abdominal, skin and skin structure infections, and traveller’s diarrhea, or even precludes the use in indications like sexually transmitted diseases and enteric fever.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
The burden of oral disease: challenges to improving oral health in the 21st century.
Petersen, P. E. (2005) · Europe PMC (PubMed Central) · Cited by 3,575
Bacteroides: the Good, the Bad, and the Nitty-Gritty
Wexler, H. M. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-07 · Cited by 2,254
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Lynfield, R., Reingold, A., Cieslak, P. R., Pilishvili, T., Jackson, D., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022823 · Cited by 2,228
Martínez, J. L. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00001 · Cited by 2,101
Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern
Pitout, J. D., & Laupland, K. B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70041-0 · Cited by 2,044
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
Workowski, K. A., & Berman, S. M. (2007) · Clinical Infectious Diseases · doi:10.1086/511430 · Cited by 1,973
David, M. Z., & Daum, R. S. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00081-09 · Cited by 1,972
Mutagenesis and inducible responses to deoxyribonucleic acid damage in Escherichia coli
Walker, G. C. (1984) · Microbiological Reviews · doi:10.1128/mmbr.48.1.60-93.1984 · Cited by 1,770
The global burden of diarrhoeal disease, as estimated from studies published between 1992 and 2000.
Kosek, M. N., Bern, C., & Guerrant, R. L. (2003) · Europe PMC (PubMed Central) · Cited by 1,617
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir034 · Cited by 1,599
Sexually Transmitted Diseases 7982 Treatment Guidelines
(1982) · American Pharmacy · doi:10.1016/s0160-3450(16)31823-2 · Cited by 1,573
Solomkin, J. S., Mazuski, J. E., Bradley, J. S., Rodvold, K. A., Goldstein, E. J. C., Baron, E. J., O'Neill, P. J., Chow, A. W., Dellinger, E. P., Eachempati, S. R., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649554 · Cited by 1,558
Multidrug-resistance efflux pumps ? not just for resistance
Piddock, L. J. V. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1464 · Cited by 1,522
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.3.377-392.1997 · Cited by 1,494
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,465
SOS response promotes horizontal dissemination of antibiotic resistance genes
Beaber, J. W., Hochhut, B., & Waldor, M. K. (2004) · Nature · doi:10.1038/nature02241 · Cited by 1,186
Global Challenge of Multidrug-Resistant Acinetobacter baumannii
Perez, F., Hujer, A. M., Hujer, K. M., Decker, B. K., Rather, P. N., & Bonomo, R. A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01464-06 · Cited by 1,139
Acquired Antibiotic Resistance Genes: An Overview
van Hoek, A. H. A. M., Mevius, D., Guerra, B., Mullany, P., Roberts, A. P., & Aarts, H. J. M. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00203 · Cited by 1,136
Quinolone resistance from a transferable plasmid
Martínez-Martínez, L., Pascual, A., & Jacoby, G. A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07322-4 · Cited by 1,100
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
Robicsek, A., Strahilevitz, J., Jacoby, G. A., Macielag, M., Abbanat, D., Hye Park, C., Bush, K., & Hooper, D. C. (2006) · Nature Medicine · doi:10.1038/nm1347 · Cited by 1,013
Decreased Susceptibility of Streptococcus pneumoniae to Fluoroquinolones in Canada
Chen, D. K., McGeer, A., de Azavedo, J. C., & Low, D. E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410403 · Cited by 987
The worldwide emergence of plasmid-mediated quinolone resistance
Robicsek, A., Jacoby, G. A., & Hooper, D. C. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70599-0 · Cited by 966
Epidemiology and Outcomes of Health-care–Associated Pneumonia
Kollef, M. H., Shorr, A., Tabak, Y. P., Gupta, V., Liu, L. Z., & Johannes, R. S. (2005) · Chest · doi:10.1378/chest.128.6.3854 · Cited by 948
Monecke, S., Coombs, G., Shore, A. C., Coleman, D. C., Akpaka, P., Borg, M., Chow, H., Ip, M., Jatzwauk, L., Jonas, D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017936 · Cited by 947
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
Strahilevitz, J., Jacoby, G. A., Hooper, D. C., & Robicsek, A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00016-09 · Cited by 928
CTX-M: changing the face of ESBLs in Europe
Livermore, D. M., Canton, R., Gniadkowski, M., Nordmann, P., Rossolini, G. M., Arlet, G., Ayala, J., Coque, T. M., Kern-Zdanowicz, I., Luzzaro, F., et al. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl483 · Cited by 927
Mechanisms of Resistance to Quinolones
Jacoby, G. A. (2005) · Clinical Infectious Diseases · doi:10.1086/428052 · Cited by 924
1993 Sexually Transmitted Diseases Treatment Guidelines
(1994) · Journal of School Health · doi:10.1111/j.1746-1561.1994.tb03287.x · Cited by 918
Marston, B. J. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440360129015 · Cited by 909
Courcelle, J., Khodursky, A., Peter, B., Brown, P. O., & Hanawalt, P. C. (2001) · Genetics · doi:10.1093/genetics/158.1.41 · Cited by 853
Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15
Nicolas-Chanoine, M.-H., Blanco, J., Leflon-Guibout, V., Demarty, R., Alonso, M. P., Canica, M. M., Park, Y.-J., Lavigne, J.-P., Pitout, J., & Johnson, J. R. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm464 · Cited by 821
Effect of antimicrobial agents on the ecological balance of human microflora
Sullivan, Å., Edlund, C., & Nord, C. E. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00066-4 · Cited by 818
Okusu, H., Ma, D., & Nikaido, H. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.1.306-308.1996 · Cited by 814
Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community
Pitout, J. D. D., Nordmann, P., Laupland, K. B., & Poirel, L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki166 · Cited by 790
"Choking game" awareness and participation among 8th graders--Oregon, 2008.
Ramowski, S. K., Nystrom, R. J., Chaumeton, N. R., Rosenberg, K., & Gilchrist, J. (2010) · MMWR Morbidity and Mortality Weekly Report · Cited by 758
Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain
Rogers, B. A., Sidjabat, H. E., & Paterson, D. L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq415 · Cited by 716
Ohnishi, M., Golparian, D., Shimuta, K., Saika, T., Hoshina, S., Iwasaku, K., Nakayama, S.-I., Kitawaki, J., & Unemo, M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00325-11 · Cited by 686
Frontiers in Microbiology: From Antibiotics to AIDS
(1987) · Springer eBooks · doi:10.1007/978-94-009-3353-8 · Cited by 664
Gupta, K. (1999) · JAMA · doi:10.1001/jama.281.8.736 · Cited by 609
Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe
Cantón, R., Novais, A., Valverde, A., Machado, E., Peixe, L., Baquero, F., & Coque, T. M. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01850.x · Cited by 599
Kahlmeter, G. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg028 · Cited by 597
SOS Response Induction by ß-Lactams and Bacterial Defense Against Antibiotic Lethality
Miller, C., Thomsen, L. E., Gaggero, C., Mosseri, R., Ingmer, H., & Cohen, S. N. (2004) · Science · doi:10.1126/science.1101630 · Cited by 584
Inhibition of Mutation and Combating the Evolution of Antibiotic Resistance
Cirz, R. T., Chin, J. K., Andes, D. R., de Crécy-Lagard, V., Craig, W. A., & Romesberg, F. E. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030176 · Cited by 576
Quinolone-Mediated Bacterial Death
Drlica, K., Malik, M., Kerns, R. J., & Zhao, X. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01617-06 · Cited by 570
Identification of additional genes belonging to the LexA regulon in Escherichia coli
Fernández de Henestrosa, A. R., Ogi, T., Aoyagi, S., Chafin, D., Hayes, J. J., Ohmori, H., & Woodgate, R. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01826.x · Cited by 570
Mechanism of plasmid-mediated quinolone resistance
Tran, J. H., & Jacoby, G. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082092899 · Cited by 564
Akram, M., Shahid, M., & Khan, A. U. (2007) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-6-4 · Cited by 561
Doern, G. V., Heilmann, K. P., Huynh, H. K., Rhomberg, P. R., Coffman, S. L., & Brueggemann, A. B. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1721-1729.2001 · Cited by 538
SOS Response Induces Persistence to Fluoroquinolones in Escherichia coli
Dörr, T., Lewis, K., & Vulić, M. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000760 · Cited by 534
Resistance to Levofloxacin and Failure of Treatment of Pneumococcal Pneumonia
Davidson, R., Cavalcanti, R., Brunton, J. L., Bast, D. J., de Azavedo, J. C. S., Kibsey, P., Fleming, C., & Low, D. E. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012122 · Cited by 533
Manges, A. R., Johnson, J. R., Foxman, B., O'Bryan, T. T., Fullerton, K. E., & Riley, L. W. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011265 · Cited by 531
Guidelines for the Selection of Anti-infective Agents for Complicated Intra-abdominal Infections
Solomkin, J. S., Mazuski, J. E., Baron, E. J., Sawyer, R. G., Nathens, A. B., DiPiro, J. T., Buchman, T., Dellinger, E. P., Jernigan, J., Gorbach, S., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/378702 · Cited by 515
Johnson, J. R., Johnston, B., Clabots, C., Kuskowski, M. A., & Castanheira, M. (2010) · Clinical Infectious Diseases · doi:10.1086/653932 · Cited by 510
Citron, D. M., Goldstein, E. J. C., Merriam, C. V., Lipsky, B. A., & Abramson, M. A. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00551-07 · Cited by 509
Gleason, P. P., Meehan, T. P., Fine, J. M., Galusha, D. H., & Fine, M. J. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.21.2562 · Cited by 496
Mechanisms of fluoroquinolone resistance
Hooper, D. C. (1999) · Drug Resistance Updates · doi:10.1054/drup.1998.0068 · Cited by 488
Woodford, N., Ward, M. E., Kaufmann, M. E., Turton, J., Fagan, E. J., James, D., Johnson, A. P., Pike, R., Warner, M., Cheasty, T., et al. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh424 · Cited by 472
Yamane, K., Wachino, J.-I., Suzuki, S., Kimura, K., Shibata, N., Kato, H., Shibayama, K., Konda, T., & Arakawa, Y. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00339-07 · Cited by 467
Jacobs, M. R. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg321 · Cited by 467
Methicillin-Resistant Staphylococcus aureus: An Evolutionary, Epidemiologic, and Therapeutic Odyssey
Deresinski, S. (2005) · Clinical Infectious Diseases · doi:10.1086/427701 · Cited by 466
“Collateral Damage” from Cephalosporin or Quinolone Antibiotic Therapy
Paterson, D. L. (2004) · Clinical Infectious Diseases · doi:10.1086/382690 · Cited by 466
Rodríguez-Baño, J., Navarro, M. D., Romero, L., Martínez-Martínez, L., Muniain, M. A., Perea, E. J., Pérez-Cano, R., & Pascual, A. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.3.1089-1094.2004 · Cited by 456
Peirano, G., & Pitout, J. D. D. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.11.003 · Cited by 443 · cited 1×
“coli is mostly due to the single CTX-M-15 positive clone ST131; foreign travel to highrisk areas, such as the Indian subcontinent, play in part a role in the spread of this clone across different continents [124].”
BackgroundMethicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology
Tenover, F. C., & Goering, R. V. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp241 · Cited by 441
Fitzgerald, J. R., Sturdevant, D. E., Mackie, S. M., Gill, S. R., & Musser, J. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161098098 · Cited by 434
Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae
Nordmann, P., & Poirel, L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki245 · Cited by 425
Community-Associated MRSA — Resistance and Virulence Converge
Chambers, H. F. (2005) · New England Journal of Medicine · doi:10.1056/nejme058023 · Cited by 423
Diep, B. A., Stone, G. G., Basuino, L., Graber, C. J., Miller, A., Etages, S. D., Jones, A., Palazzolo‐Ballance, A. M., Perdreau‐Remington, F., Sensabaugh, G. F., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/587907 · Cited by 422
Schito, G. C., Naber, K. G., Botto, H., Palou, J., Mazzei, T., Gualco, L., & Marchese, A. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.04.012 · Cited by 421
Graffunder, E. M. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf009 · Cited by 411
Mechanisms of Action and Resistance of Older and Newer Fluoroquinolones
Hooper, D. C. (2000) · Clinical Infectious Diseases · doi:10.1086/314056 · Cited by 409
Origin of Plasmid-Mediated Quinolone Resistance Determinant QnrA
Poirel, L., Rodriguez-Martinez, J.-M., Mammeri, H., Liard, A., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3523-3525.2005 · Cited by 394
Spontaneous bacterial peritonitis: recent guidelines and beyond
Wiest, R., Krag, A., & Gerbes, A. (2012) · Gut · doi:10.1136/gutjnl-2011-300779 · Cited by 386
Pitout, J. D. D. (2010) · Drugs · doi:10.2165/11533040-000000000-00000 · Cited by 376
Hoban, D. J., Doern, G. V., Fluit, A. C., Roussel‐Delvallez, M., & Jones, R. N. (2001) · Clinical Infectious Diseases · doi:10.1086/320181 · Cited by 375
Infective Exacerbations of Chronic Bronchitis
Eller, J., Ede, A., Schaberg, T., Niederman, M. S., Mauch, H., & Lode, H. (1998) · Chest · doi:10.1378/chest.113.6.1542 · Cited by 373
Karlowsky, J. A., Kelly, L. J., Thornsberry, C., Jones, M. E., & Sahm, D. F. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2540-2545.2002 · Cited by 367
Complicated skin and soft tissue infection
Dryden, M. S. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq302 · Cited by 366
Maiques, E., Úbeda, C., Campoy, S., Salvador, N., Lasa, I., Novick, R. P., Barbé, J., & Penadés, J. R. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.7.2726-2729.2006 · Cited by 365
Everett, M. J., Jin, Y. F., Ricci, V, & Piddock, L. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2380 · Cited by 365
Effects of Antibiotics on Quorum Sensing in Pseudomonas aeruginosa
Skindersoe, M. E., Alhede, M., Phipps, R., Yang, L., Jensen, P. O., Rasmussen, T. B., Bjarnsholt, T., Tolker-Nielsen, T., Høiby, N., & Givskov, M. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01230-07 · Cited by 364
Groom, A. V. (2001) · JAMA · doi:10.1001/jama.286.10.1201 · Cited by 360
Song, J.-H., Jung, S.-I., Ko, K. S., Kim, N. Y., Son, J. S., Chang, H.-H., Ki, H. K., Oh, W. S., Suh, J. Y., Peck, K. R., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2101-2107.2004 · Cited by 359
Fey, P. D., Saïd-Salim, B., Rupp, M. E., Hinrichs, S. H., Boxrud, D. J., Davis, C. C., Kreiswirth, B. N., & Schlievert, P. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.196-203.2003 · Cited by 352
Karlowsky, J. A., Draghi, D. C., Jones, M. E., Thornsberry, C., Friedland, I. R., & Sahm, D. F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1681-1688.2003 · Cited by 351
Rodríguez‐Baño, J., Picón, E., Gijón, P., Hernández, J. R., Ruíz, M., Peña, C., Almela, M., Almirante, B., Grill, F., Colomina, J., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649537 · Cited by 347
A Critical Review of the Fluoroquinolones: Focus on Respiratory Infections
Zhanel, G. G., Ennis, K., Vercaigne, L., Walkty, A., Gin, A. S., Embil, J., Smith, H., & Hoban, D. J. (2002) · Drugs · doi:10.2165/00003495-200262010-00002 · Cited by 344
Emergence and Dissemination of Quinolone-Resistant Escherichia coli in the Community
Garau, J., Xercavins, M., Rodríguez-Carballeira, M., Gómez-Vera, J. R., Coll, I., Vidal, D., Llovet, T., & Ruíz-Bremón, A. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2736 · Cited by 337
Gorak, E. J., Yamada, S. M., & Brown, J. D. (1999) · Clinical Infectious Diseases · doi:10.1086/520437 · Cited by 332
Eady, E. A., & Cove, J. H. (2003) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200304000-00007 · Cited by 329
Trends in US Hospital Admissions for Skin and Soft Tissue Infections
Edelsberg, J., Taneja, C., Zervos, M., Haque, N., Moore, C., Reyes, K., Spalding, J., Jiang, J., & Oster, G. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1509.081228 · Cited by 326
Fluoroquinolone resistance among Gram-positive cocci
Hooper, D. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00369-9 · Cited by 320
Farrell, D. J., Morrissey, I., De Rubeis, D., Robbins, M., & Felmingham, D. (2003) · Journal of Infection · doi:10.1053/jinf.2002.1091 · Cited by 320
Blumberg, H. M., Rimland, D., Carroll, D. J., Terry, & Wachsmuth, I. K. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.6.1279 · Cited by 319
Naber, K. G., Schito, G., Botto, H., Palou, J., & Mazzei, T. (2008) · European Urology · doi:10.1016/j.eururo.2008.05.010 · Cited by 316
Immunomodulatory effects of quinolones
Dalhoff, A., & Shalit, I. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00658-3 · Cited by 310
Self-citationPlasmid-mediated quinolone resistance: an update
Rodríguez-Martínez, J. M., Velasco, C., Pascual, Á., Cano, M. E., Martínez-Martínez, L., Martínez-Martínez, L., & Pascual, Á. (2011) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-010-0120-2 · Cited by 306
Calbo, E., Romaní, V., Xercavins, M., Gómez, L., Vidal, C. G., Quintana, S., Vila, J., & Garau, J. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl035 · Cited by 305
ZHANEL, G., HISANAGA, T., LAING, N., DECORBY, M., NICHOL, K., WESHNOWESKI, B., JOHNSON, J., NOREDDIN, A., LOW, D., & KARLOWSKY, J. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.02.009 · Cited by 302
Factors influencing methicillin resistance in staphylococci
Berger-Bächi, B., & Rohrer, S. (2002) · Archives of Microbiology · doi:10.1007/s00203-002-0436-0 · Cited by 301
Thornsberry, C., Jones, M. E., Hickey, M. L., Mauriz, Y., Kahn, J., & Sahm, D. F. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.6.749 · Cited by 300
Defining, treating and preventing hospital acquired pneumonia: European perspective
Torres, A., Ewig, S., Lode, H., Carlet, J., & For The European HAP working group (2009) · Intensive Care Medicine · doi:10.1007/s00134-008-1336-9 · Cited by 298
Mechanisms of quinolone action and microbial response
Hawkey, P. M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg207 · Cited by 288
Arslan, H., Azap, Ö. K., Ergönül, Ö., & Timurkaynak, F. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki344 · Cited by 286
Wang, H., Dzink-Fox, J. L., Chen, M., & Levy, S. B. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1515-1521.2001 · Cited by 284
CTX-M: changing the face of ESBLs in the UK
Livermore, D. M., & Hawkey, P. M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki239 · Cited by 278
Nagy, E., Urbán, E., & Nord, C. E. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03256.x · Cited by 277
Poirel, L., Cattoir, V., & Nordmann, P. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00024 · Cited by 276
Complete and SOS-Mediated Response of Staphylococcus aureus to the Antibiotic Ciprofloxacin
Cirz, R. T., Jones, M. B., Gingles, N. A., Minogue, T. D., Jarrahi, B., Peterson, S. N., & Romesberg, F. E. (2007) · Journal of Bacteriology · doi:10.1128/jb.01464-06 · Cited by 273
Zhanel, G. G., DeCorby, M., Laing, N., Weshnoweski, B., Vashisht, R., Tailor, F., Nichol, K. A., Wierzbowski, A., Baudry, P. J., Karlowsky, J. A., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01538-07 · Cited by 271
oqxAB Encoding a Multidrug Efflux Pump in Human Clinical Isolates of Enterobacteriaceae
Kim, H. B., Wang, M., Park, C. H., Kim, E.-C., Jacoby, G. A., & Hooper, D. C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01574-08 · Cited by 271
UK national guideline for the management of gonorrhoea in adults, 2011
Bignell, C., FitzGerald, M., & (Guideline Development Group) (2011) · International Journal of STD & AIDS · doi:10.1258/ijsa.2011.011267 · Cited by 270
Jones, M. E., Draghi, D. C., Thornsberry, C., Karlowsky, J. A., Sahm, D. F., & Wenzel, R. P. (2004) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-3-14 · Cited by 269
Jiang, Z., Lowe, B., Verenkar, M. P., Ashley, D., Steffen, R., Tornieporth, N., von Sonnenburg, F., Waiyaki, P., & DuPont, H. L. (2002) · The Journal of Infectious Diseases · doi:10.1086/338834 · Cited by 268
Oliver, A., Baquero, F., & Blázquez, J. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02855.x · Cited by 267
Périchon, B., Courvalin, P., & Galimand, M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00143-07 · Cited by 266
Population Mobility, Globalization, and Antimicrobial Drug Resistance
MacPherson, D. W. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1511.090419 · Cited by 266
Johnson, J. R., Menard, M., Johnston, B., Kuskowski, M. A., Nichol, K., & Zhanel, G. G. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00297-09 · Cited by 265
Hansen, L. H., Jensen, L. B., Sørensen, H. I., & Sørensen, S. J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm167 · Cited by 258
Predicting Antimicrobial Resistance in Invasive Pneumococcal Infections
Vanderkooi, O. G., Low, D. E., Green, K., Powis, J. E., McGeer, A., & for the Toronto Invasive Bacterial Disease Network (2005) · Clinical Infectious Diseases · doi:10.1086/429242 · Cited by 257
(2007) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2007.06.012 · Cited by 253
Johnson, A. P. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.1.143 · Cited by 247
Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives
Kluytmans-VandenBergh, M. F. Q., & Kluytmans, J. A. J. W. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01341.x · Cited by 243
Ho, P.-L., Que, T.-L., Tsang, D. N.-C., Ng, T.-K., Chow, K.-H., & Seto, W.-H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1310 · Cited by 241
Ceftriaxone-Resistant Neisseria gonorrhoeae , Japan
Ohnishi, M., Saika, T., Hoshina, S., Iwasaku, K., Nakayama, S.-I., Watanabe, H., & Kitawaki, J. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1701.100397 · Cited by 236
Cattoir, V., Poirel, L., Aubert, C., Soussy, C.-J., & Nordmann, P. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1402.070677 · Cited by 229
Jones, M. E., Karlowsky, J. A., Draghi, D. C., Thornsberry, C., Sahm, D. F., & Nathwani, D. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(03)00154-7 · Cited by 227
Hawser, S. P., Bouchillon, S. K., Hoban, D. J., Badal, R. E., Hsueh, P.-R., & Paterson, D. L. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00426-09 · Cited by 224
Plasmid-Encoded Multidrug Efflux Pump Conferring Resistance to Olaquindox in Escherichia coli
Hansen, L. H., Johannesen, E., Burmølle, M., Sørensen, A. H., & Sørensen, S. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3332-3337.2004 · Cited by 215
DNA topoisomerase targets of the fluoroquinolones: A strategy for avoiding bacterial resistance
Zhao, X., Xu, C., Domagala, J., & Drlica, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13991 · Cited by 213
Oethinger, M., Kern, W. V., Jellen-Ritter, A. S., McMurry, L. M., & Levy, S. B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.10-13.2000 · Cited by 213
Pérez-Trallero, E., Fernández-Mazarrasa, C., Garcı́a-Rey, C., Bouza, E., Aguilar, L., Garcı́a-de-Lomas, J., Baquero, F., & The Spanish Surveillance Group for Respiratory Pathogens (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3334-3340.2001 · Cited by 210
Liu, C., Graber, C. J., Karr, M., Diep, B. A., Basuino, L., Schwartz, B. S., Enright, M. C., O’Hanlon, S. J., Thomas, J. C., Perdreau‐Remington, F., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/587893 · Cited by 205
Immunomodulatory Activities of Fluoroquinolones
Dalhoff, A. (2005) · Infection · doi:10.1007/s15010-005-8209-8 · Cited by 203
Self-citationJacoby, G., Cattoir, V., Hooper, D., Martínez-Martínez, L., Nordmann, P., Pascual, A., Poirel, L., & Wang, M. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00147-08 · Cited by 202
Doern, G. V., Richter, S. S., Miller, A., Miller, N., Rice, C., Heilmann, K., & Beekmann, S. (2005) · Clinical Infectious Diseases · doi:10.1086/430906 · Cited by 196
Song, J.-H., Oh, W. S., Kang, C.-I., Chung, D. R., Peck, K. R., Ko, K. S., Yeom, J. S., Kim, C. K., Kim, S. W., Chang, H.-H., et al. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.09.014 · Cited by 195
Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance
Oliver, A., & Mena, A. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03250.x · Cited by 194
Pitout, J. D. D., Hanson, N. D., Church, D. L., & Laupland, K. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421094 · Cited by 192
Dynamics and Spatial Distribution of β-Lactamase Expression in Pseudomonas aeruginosa Biofilms
Bagge, N., Hentzer, M., Andersen, J. B., Ciofu, O., Givskov, M., & Høiby, N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1168-1174.2004 · Cited by 192
Foweraker, J. E. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki146 · Cited by 184
Paterson, D. L., Rossi, F., Baquero, F., Hsueh, P.-R., Woods, G. L., Satishchandran, V., Snyder, T. A., Harvey, C. M., Teppler, H., DiNubile, M. J., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki117 · Cited by 184
Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe
Hedberg, M. H., & Nord, C. E. (2003) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2003.00674.x · Cited by 182
Azap, Ö. K., Arslan, H., Şerefhanoğlu, K., Çolakoğlu, Ş., Erdoğan, H., Timurkaynak, F., & Senger, S. S. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02941.x · Cited by 180
Prevalence of Antibiotic Resistance in Anaerobic Bacteria: Worrisome Developments
Hecht, D. W. (2004) · Clinical Infectious Diseases · doi:10.1086/421558 · Cited by 174
Bambeke, F., Pages, J.-M., & Lee, V. (2006) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/157489106777452692 · Cited by 171
Quorum Sensing Inhibition Selects for Virulence and Cooperation in Pseudomonas aeruginosa
Köhler, T., Perron, G. G., Buckling, A., & van Delden, C. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000883 · Cited by 171
Cagnacci, S., Gualco, L., Debbia, E., Schito, G. C., & Marchese, A. (2008) · Journal of Clinical Microbiology · doi:10.1128/jcm.00640-08 · Cited by 166
Zhanel, G. G., DeCorby, M., Adam, H., Mulvey, M. R., McCracken, M., Lagacé-Wiens, P., Nichol, K. A., Wierzbowski, A., Baudry, P. J., Tailor, F., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00469-10 · Cited by 166
Karlowsky, J. A., Thornsberry, C., Jones, M. E., Evangelista, A. T., Critchley, I. A., & Sahm, D. F. (2003) · Clinical Infectious Diseases · doi:10.1086/374052 · Cited by 165
Steep rise in notified hantavirus infections in Germany, April 2010
Faber, M. S., Ulrich, R. G., Frank, C., Brockmann, S. O., Pfaff, G. M., Jacob, J., Krüger, D. H., & Stark, K. (2010) · Eurosurveillance · doi:10.2807/ese.15.20.19574-en · Cited by 164
Reinert, R. R., Reinert, S., van der Linden, M., Cil, M. Y., Al-Lahham, A., & Appelbaum, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.7.2903-2913.2005 · Cited by 164
Oethinger, M., Podglajen, I., Kern, W. V., & Levy, S. B. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.2089 · Cited by 164
Liu, C.-Y., Huang, Y.-T., Liao, C.-H., Yen, L.-C., Lin, H.-Y., & Hsueh, P.-R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00355-08 · Cited by 162
Zhanel, G. G., Palatnick, L., Nichol, K. A., Bellyou, T., Low, D. E., & Hoban, D. J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.6.1867-1874.2003 · Cited by 161
Mechanisms Accounting for Fluoroquinolone Resistance in Escherichia coli Clinical Isolates
Morgan-Linnell, S. K., Becnel Boyd, L., Steffen, D., & Zechiedrich, L. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00665-08 · Cited by 161
Sahm, D. F., Jones, M. E., Hickey, M. L., Diakun, D. R., Mani, S. V., & Thornsberry, C. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.4.457 · Cited by 161
Mendonça, N., Leitão, J., Manageiro, V., Ferreira, E., & Caniça, M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01412-06 · Cited by 160
Chua, K., Laurent, F., Coombs, G., Grayson, M. L., & Howden, B. P. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq067 · Cited by 159
Goldstein, E. J. C., Citron, D. M., & Nesbit, C. A. (1996) · Diabetes Care · doi:10.2337/diacare.19.6.638 · Cited by 159
Workowski, K. A., Berman, S. M., & Douglas, J. M. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-8-200804150-00005 · Cited by 158
Emergence of Fluoroquinolone Resistance in Outpatient Urinary Escherichia coli Isolates
Johnson, L. M., Sabel, A. L., Burman, W. J., Everhart, R. M., Rome, M., MacKenzie, T. D., Rozwadowski, J. M., Mehler, P. S., & Price, C. S. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.04.039 · Cited by 156
Felmingham, D., Grüneberg, R. N., & The Alexander Project Group (1996) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/38.suppl_a.1 · Cited by 156
Rolain, J., François, P., Hernández, D., Bittar, F., Richet, H., Fournous, G., Mattenberger, Y., Bosdure, E., Stremler, N., Dubus, J. ‐., et al. (2009) · Biology Direct · doi:10.1186/1745-6150-4-1 · Cited by 152
Fitness Costs of Fluoroquinolone Resistance in Streptococcus pneumoniae
Rozen, D. E., McGee, L., Levin, B. R., & Klugman, K. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01161-06 · Cited by 151
Hsueh, P., Hoban, D. J., Carmeli, Y., Chen, S., Desikan, S., Alejandria, M., Ko, W., & Bình, T. Q. (2011) · Journal of Infection · doi:10.1016/j.jinf.2011.05.015 · Cited by 149
Taylor, D. N., Bourgeois, A. L., Ericsson, C. D., Steffen, R. J., Jiang, Z., Halpern, J. L., Haake, R. J., DuPont, H. L., & _, _. (2006) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2006.74.1060 · Cited by 148
Pitt, T. L. (2003) · Thorax · doi:10.1136/thorax.58.9.794 · Cited by 147
Vetting, M. W., Park, C. H., Hegde, S. S., Jacoby, G. A., Hooper, D. C., & Blanchard, J. S. (2008) · Biochemistry · doi:10.1021/bi800664x · Cited by 146
Vibrionaceae as a possible source of Qnr-like quinolone resistance determinants
Poirel, L., Liard, A., Rodríguez-Martínez, J. M., & Nordmann, P. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki371 · Cited by 146
Antimicrobial-resistant InvasiveEscherichia coli, Spain
Oteo, J., Lázaro, E., de Abajo, F. J., Baquero, F., Campos, J., & EARSS, S. M. O. (2005) · Emerging infectious diseases · doi:10.3201/eid1104.040699 · Cited by 145
Han, L. L., McDougal, L. K., Gorwitz, R. J., Mayer, K. H., Patel, J. B., Sennott, J. M., & Fontana, J. L. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.02274-06 · Cited by 144
Alós, J.-I., Serrano, M. G., Gómez‐Garcés, J. L., & Perianes, J. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01057.x · Cited by 143
Impact of Clinical Guidelines in the Management of Severe Hospital-Acquired Pneumonia
Hoo, G. W. S., Wen, Y., Nguyen, T. V., & Goetz, M. B. (2005) · CHEST Journal · doi:10.1378/chest.128.4.2778 · Cited by 143
Knight, G. M., Budd, E. L., Whitney, L., Thornley, A., Al-Ghusein, H., Planche, T., & Lindsay, J. A. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks245 · Cited by 143
López‐Camacho, E., Elez, M., Matić, I., & Blázquez, J. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05642.x · Cited by 143
Quinolone Resistance: Much More than Predicted
Hernández, A., Sánchez, M. B., & Martínez, J. L. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00022 · Cited by 142
Fluoroquinolone Resistance in Streptococcus pneumoniae in United States since 1994-1995
Brueggemann, A. B., Coffman, S. L., Rhomberg, P. R., Huynh, H. K., Almer, L. S., Nilius, A. M., Flamm, R. K., & Doern, G. V. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.680-688.2002 · Cited by 141
Doern, G. V., Jones, R. N., Pfaller, M. A., Kugler, K. C., & Beach, M. L. (1999) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00162-x · Cited by 140
Ysern, P., Clerch, B., Castańo, M., Gibert, I., Barbé, J., & Llagostera, M. (1990) · Mutagenesis · doi:10.1093/mutage/5.1.63 · Cited by 140
In Vitro Antibacterial Activity and Pharmacodynamics of New Quinolones
Dalhoff, A., & Schmitz, F. (2003) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-0907-5 · Cited by 136
Self-citationGomi, H., Jiang, Z., Adachi, J. A., Ashley, D., Lowe, B. S., Verenkar, M. P., Steffen, R. J., & DuPont, H. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.212-216.2001 · Cited by 135
Surveillance of antimicrobial resistance — what, how and whither?
Bax, R. P., Bywater, R., Cornaglia, G., Goossens, H., Hunter, P., Isham, V. S., Jarlier, V., Jones, R. N., Phillips, I., Sahm, D. F., et al. (2001) · Clinical Microbiology and Infection · doi:10.1046/j.1198-743x.2001.00239.x · Cited by 132
Shimada, Y., Deguchi, T., Nakane, K., et al. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.05.011 · Cited by 132
Ventilator-associated pneumonia: A review
Joseph, N. M., Sistla, S., Dutta, T. K., et al. (2010) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2010.07.006 · Cited by 130
Trung, N. V., Le, P. V., Huy, C. L., & Weintraub, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.816-819.2005 · Cited by 128
Pitout, J. D. D., Church, D. L., Gregson, D. B., Chow, B. L., McCracken, M., Mulvey, M. R., & Laupland, K. B. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01377-06 · Cited by 126
Drug‐Resistant Pneumococcal Pneumonia: Clinical Relevance and Related Factors
Aspa, J., Rajas, O., de Castro, F. R., Blanquer, J., Zalacaín, R., Fenoll, A., Celis, R., Vargas, A., Salvanés, F. R., España, P. P., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/381886 · Cited by 126
Antimicrobial resistance in Neisseria gonorrhoeae
TAPSALL, J. W. (2001) · Cited by 124
Mazzariol, A., Tokue, Y., Kanegawa, T. M., Cornaglia, G., & Nikaido, H. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3441-3443.2000 · Cited by 124
van der Starre, W. E., van Nieuwkoop, C., Paltansing, S., Wout, J. W. V., Groeneveld, G. H., Becker, M. J., Koster, T., Wattel-Louis, G. H., Delfos, N. M., Ablij, H. C., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq465 · Cited by 123
Sahm, D. F., Karlowsky, J. A., Kelly, L. J., Critchley, I. A., Jones, M. E., Thornsberry, C., Mauriz, Y., & Kahn, J. B. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1037-1042.2001 · Cited by 121
Dziekan, G., Hahn, A., Thüne, K., Schwarzer, G., Schäfer, K., Daschner, F. D., & Grundmann, H. (2000) · Journal of Hospital Infection · doi:10.1053/jhin.2000.0846 · Cited by 120
Bisognano, C., Vaudaux, P. E., Rohner, P., Lew, D. P., & Hooper, D. C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1428-1437.2000 · Cited by 119
Treatment Guidelines and Outcomes of Hospital‐Acquired and Ventilator‐Associated Pneumonia
Torres, A., Ferrer, M., & Badia, J. R. (2010) · Clinical Infectious Diseases · doi:10.1086/653049 · Cited by 119
Martin, I. M. C. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl265 · Cited by 119
Montero, C. I., Mateu, G., Rodríguez, R., & Takiff, H. E. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3387-3392.2001 · Cited by 117
Talan, D. A., Krishnadasan, A., Abrahamian, F. M., Stamm, W. E., Moran, G. J., & EMERGEncy ID NET Study Group (2008) · Clinical Infectious Diseases · doi:10.1086/592250 · Cited by 117
Cited by
Systematic Review of Complications of Prostate Biopsy
Loeb, S., Vellekoop, A., Ahmed, H. U., Catto, J., Emberton, M., Nam, R., Rosario, D. J., Scattoni, V., & Lotan, Y. (2013) · European Urology · doi:10.1016/j.eururo.2013.05.049 · Cited by 1,073
Drugging Topoisomerases: Lessons and Challenges
Pommier, Y. (2013) · ACS Chemical Biology · doi:10.1021/cb300648v · Cited by 839
Horizontal transfer of antibiotic resistance genes in clinical environments
Lerminiaux, N. A., & Cameron, A. D. S. (2019) · Canadian Journal of Microbiology · doi:10.1139/cjm-2018-0275 · Cited by 802
Pham, T. D. M., Ziora, Z. M., & Blaskovich, M. A. T. (2019) · MedChemComm · doi:10.1039/c9md00120d · Cited by 785
The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection
Mazuski, J. E., Tessier, J. M., May, A. K., Sawyer, R. G., Nadler, E. P., Rosengart, M. R., Chang, P. K., O'Neill, P. J., Mollen, K. P., Huston, J. M., et al. (2017) · Surgical Infections · doi:10.1089/sur.2016.261 · Cited by 573
Metadata
- Authors
- Dalhoff, A.
- Venue
- Interdisciplinary Perspectives on Infectious Diseases
- Publisher
- Wiley
- Published
- 2012
- Volume
- 2012
- Pages
- 1-37
- ISSN
- 1687-708X (ISSN-L)
- 1687-7098
- OpenAlex
- W2046548856
- Cited by
- 354
- References
- 332
- FWCI
- 7.04
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.